GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinphar Pharmaceutical Co Ltd (TPE:1734) » Definitions » Inventories, Finished Goods

Sinphar Pharmaceutical Co (TPE:1734) Inventories, Finished Goods : NT$0 Mil (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinphar Pharmaceutical Co Inventories, Finished Goods?


Sinphar Pharmaceutical Co Inventories, Finished Goods Historical Data

The historical data trend for Sinphar Pharmaceutical Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinphar Pharmaceutical Co Inventories, Finished Goods Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sinphar Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sinphar Pharmaceutical Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Sinphar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.

Sinphar Pharmaceutical Co Headlines

No Headlines